MAIT cells, surveyors of a new class of antigen: Development and functions

Current Opinion in Immunology

Volumn 25, Issue 2, 2013, Pages 174-180

  Le Bourhis, Lionel ^a   Mburu, Yvonne K ^a   Lantz, Olivier ^a,b  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORRINOID DERIVATIVE; GAMMA INTERFERON; HLA B ANTIGEN; INTERLEUKIN 17; MR1 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN B GROUP;

BACTERIUM; CYTOKINE RELEASE; HEMATOPOIETIC CELL; HUMAN; LIVER; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MUCOSAL ASSOCIATED INVARIANT T LYMPHOCYTE; NONHUMAN; PHENOTYPE; REVIEW; T LYMPHOCYTE SUBPOPULATION; THYMUS; YEAST;

ANIMALS; ANTIGENS; HUMANS; T-LYMPHOCYTES; VITAMIN B COMPLEX;

EID: 84877044428     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.01.005     Document Type: Review

References (60)

1. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
2. Gold M.C., Lewinsohn D.M. Mucosal associated invariant T cells and the immune response to infection. Microbes Infect 2011, 13:742-748.
3. Le Bourhis L., Guerri L., Dusseaux M., Martin E., Soudais C., Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 2011, 32:212-218.
4. Treiner E., Duban L., Moura I.C., Hansen T., Gilfillan S., Lantz O. Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect 2005, 7:552-559.
5. Treiner E., Lantz O. CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol 2006, 18:519-526.
6. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., Kronenberg M. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998, 188:1521-1528.
7. Le Bourhis L., Martin E., Peguillet I., Guihot A., Froux N., Core M., Levy E., Dusseaux M., Meyssonnier V., Premel V., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010, 11:701-708.
8. Martin E., Treiner E., Duban L., Guerri L., Laude H., Toly C., Premel V., Devys A., Moura I.C., Tilloy F., et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol 2009, 7:e54.
9. Havenith S.H., Yong S.L., Henson S.M., Piet B., Idu M.M., Koch S.D., Jonkers R.E., Kragten N.A., Akbar A.N., van Lier R.A., et al. Analysis of stem-cell-like properties of human CD161++IL-18Ralpha+ memory CD8+ T cells. Int Immunol 2012, 24:625-636.
10. Turtle C.J., Delrow J., Joslyn R.C., Swanson H.M., Basom R., Tabellini L., Delaney C., Heimfeld S., Hansen J.A., Riddell S.R. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8alpha semi-invariant T cells. Blood 2011, 118:2752-2762.
11. Walker L.J., Kang Y.H., Smith M.O., Tharmalingham H., Ramamurthy N., Fleming V.M., Sahgal N., Leslie A., Oo Y., Geremia A., et al. Human MAIT and CD8alphaalpha cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 2012, 119:422-433.
12. Dusseaux M., Martin E., Serriari N., Peguillet I., Premel V., Louis D., Milder M., Le Bourhis L., Soudais C., Treiner E., et al. Human MAIT cells are xenobiotic resistant, tissue-targeted, CD161hi IL-17 secreting T cells. Blood 2011, 117:1250-1259.
13. Gold M.C., Eid T., Smyk-Pearson S., Eberling Y., Swarbrick G.M., Langley S.M., Streeter P.R., Lewinsohn D.A., Lewinsohn D.M. Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol 2012, 6:35-44.
14. Kjer-Nielsen L., Patel O., Corbett A.J., Le Nours J., Meehan B., Liu L., Bhati M., Chen Z., Kostenko L., Reantragoon R., et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012, 491:717-723.
15. Billerbeck E., Kang Y.H., Walker L., Lockstone H., Grafmueller S., Fleming V., Flint J., Willberg C.B., Bengsch B., Seigel B., et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A 2010, 107:3006-3011.
16. Guillot-Delost M., Le Gouvello S., Mesel-Lemoine M., Cherai M., Baillou C., Simon A., Levy Y., Weiss L., Louafi S., Chaput N., et al. Human CD90 identifies Th17/Tc17 T cell subsets that are depleted in HIV-infected patients. J Immunol 2012, 188:981-991.
17. Hildebrandt M., Dijkstra D., Gollasch H., Daemen K., Stevanovic-Meyer M., Ludwig W.D. Apheresis-related enrichment of CD26++ T lymphocytes: phenotypic characterization and correlation with unfavorable outcome in autologous hematopoietic progenitor cell transplantation. Transfusion (Paris) 2012, 52:765-776.
18. Kondo T., Takata H., Matsuki F., Takiguchi M. Cutting edge: phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J Immunol 2009, 182:1794-1798.
19. Kondo T., Takata H., Takiguchi M. Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells. Eur J Immunol 2007, 37:54-65.
20. Lecureuil C., Combadiere B., Mazoyer E., Bonduelle O., Samri A., Autran B., Debre P., Combadiere C. Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients. Blood 2007, 109:3649-3657.
21. Matteucci E., Ghimenti M., Consani C., Di Beo S., Giampietro O. About CD26 CD8 lymphocytes in type 1 diabetes mellitus. Scand J Immunol 2010, 71:123-124.
22. Northfield J.W., Kasprowicz V., Lucas M., Kersting N., Bengsch B., Kim A., Phillips R.E., Walker B.D., Thimme R., Lauer G., et al. CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 2008, 47:396-406.
23. Singh S.P., Zhang H.H., Foley J.F., Hedrick M.N., Farber J.M. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 2008, 180:214-221.
24. Takahashi T., Dejbakhsh-Jones S., Strober S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 2006, 176:211-216.
25. Turtle C.J., Swanson H.M., Fujii N., Estey E.H., Riddell S.R. A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity 2009, 31:834-844.
26. Tilloy F., Treiner E., Park S.H., Garcia C., Lemonnier F., de la Salle H., Bendelac A., Bonneville M., Lantz O. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med 1999, 189:1907-1921.
27. Treiner E., Duban L., Bahram S., Radosavljevic M., Wanner V., Tilloy F., Affaticati P., Gilfillan S., Lantz O. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003, 422:164-169.
28. Gold M.C., Cerri S., Smyk-Pearson S., Cansler M.E., Vogt T.M., Delepine J., Winata E., Swarbrick G.M., Chua W.J., Yu Y.Y., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010, 8:e1000407.
29. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529.
30. Huang S., Martin E., Kim S., Yu L., Soudais C., Fremont D.H., Lantz O., Hansen T.H. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A 2009, 106:8290-8295.
31. Riegert P., Wanner V., Bahram S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J Immunol 1998, 161:4066-4077.
32. Goldfinch N., Reinink P., Connelley T., Koets A., Morrison I., Van Rhijn I. Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen. Vet Res 2010, 41:62.
33. Hansen T.H., Huang S., Arnold P.L., Fremont D.H. Patterns of nonclassical MHC antigen presentation. Nat Immunol 2007, 8:563-568.
34. Miley M.J., Truscott S.M., Yu Y.Y., Gilfillan S., Fremont D.H., Hansen T.H., Lybarger L. Biochemical features of the MHC-related protein 1 consistent with an immunological function. J Immunol 2003, 170:6090-6098.
35. Chua W.J., Kim S., Myers N., Huang S., Yu L., Fremont D.H., Diamond M.S., Hansen T.H. Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells. J Immunol 2011, 186:4744-4750.
36. Huang S., Gilfillan S., Kim S., Thompson B., Wang X., Sant A.J., Fremont D.H., Lantz O., Hansen T.H. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med 2008, 205:1201-1211.
37. Greenaway H.Y., Ng B., Price D.A., Douek D.C., Davenport M.P., Venturi V. NKT and MAIT invariant TCRalpha sequences can be produced efficiently by VJ gene recombination. Immunobiology 2012, 218:213-224.
38. Huang S., Gilfillan S., Cella M., Miley M.J., Lantz O., Lybarger L., Fremont D.H., Hansen T.H. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem 2005, 280:21183-21193.
39. Reantragoon R., Kjer-Nielsen L., Patel O., Chen Z., Illing P.T., Bhati M., Kostenko L., Bharadwaj M., Meehan B., Hansen T.H., et al. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J Exp Med 2012, 209:761-774.
40. Kreslavsky T., Savage A.K., Hobbs R., Gounari F., Bronson R., Pereira P., Pandolfi P.P., Bendelac A., von Boehmer H. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A 2009, 106:12453-12458.
41. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., Lantz O., Bendelac A. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29:391-403.
42. Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D.G., Mamchak A.A., Terhorst C., Bendelac A. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007, 27:751-762.
43. Fergusson J.R., Fleming V.M., Klenerman P. CD161-expressing human T cells. Front Immunol 2011, 2:36.
44. Georgel P., Radosavljevic M., Macquin C., Bahram S. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol 2011, 48:769-775.
45. Chua W.J., Truscott S.M., Eickhoff C.S., Blazevic A., Hoft D.F., Hansen T.H. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun 2012, 80:3256-3267.
46. Klenerman P., Thimme R. T cell responses in hepatitis C: the good, the bad and the unconventional. Gut 2012, 61:1226-1234.
47. Germain C., Meier A., Jensen T., Knapnougel P., Poupon G., Lazzari A., Neisig A., Hakansson K., Dong T., Wagtmann N., et al. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-gamma contributes to modulate immune responses. J Biol Chem 2011, 286:37964-37975.
48. Cosgrove C., Ussher J.E., Rauch A., Gartner K., Kurioka A., Huhn M.H., Adelmann K., Kang Y.H., Fergusson J.R., Simmonds P., et al. Early and non-reversible decrease of CD161++/MAIT cells in HIV infection. Blood 2013, [Epub ahead of print].
49. Leeansyah E., Ganesh A., Quigley M.F., Sonnerborg A., Andersson J., Hunt P.W., Somsouk M., Deeks S.G., Martin J.N., Moll M., et al. Activation, exhaustion and persistent decline of the anti-microbial MR1-restricted MAIT cell population in chronic HIV-1 infection. Blood 2013, [Epub ahead of print].
50. Illes Z., Shimamura M., Newcombe J., Oka N., Yamamura T. Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol 2004, 16:223-230.
51. Croxford J.L., Miyake S., Huang Y.Y., Shimamura M., Yamamura T. Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol 2006, 7:987-994.
52. Peterfalvi A., Gomori E., Magyarlaki T., Pal J., Banati M., Javorhazy A., Szekeres-Bartho J., Szereday L., Illes Z. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol 2008, 20:1517-1525.
53. Annibali V., Ristori G., Angelini D.F., Serafini B., Mechelli R., Cannoni S., Romano S., Paolillo A., Abderrahim H., Diamantini A., et al. CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis. Brain 2010, 134:542-554.
54. Miyazaki Y., Miyake S., Chiba A., Lantz O., Yamamura T. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol 2011, 23:529-535.
55. Ponsonby A.L., van der Mei I., Dwyer T., Blizzard L., Taylor B., Kemp A., Simmons R., Kilpatrick T. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 2005, 293:463-469.
56. Matteucci E., Ghimenti M., Di Beo S., Giampietro O. Altered proportions of naive, central memory and terminally differentiated central memory subsets among CD4+ and CD8 + T cells expressing CD26 in patients with type 1 diabetes. J Clin Immunol 2011, 31:977-984.
57. Eidson M., Wahlstrom J., Beaulieu A.M., Zaidi B., Carsons S.E., Crow P.K., Yuan J., Wolchok J.D., Horsthemke B., Wieczorek D., et al. Altered development of NKT cells, gammadelta T cells, CD8 T cells and NK cells in a PLZF deficient patient. PLoS One 2011, 6:e24441.
58. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., Fernandes G.R., Tap J., Bruls T., Batto J.M., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
59. Ochoa-Reparaz J., Mielcarz D.W., Begum-Haque S., Kasper L.H. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011, 69:240-247.
60. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.